These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2966270)

  • 1. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
    Brezinski ME; Yanagisawa A; Darius H; Lefer AM
    Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia.
    Brezinski ME; Yanagisawa A; Lefer AM
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):65-71. PubMed ID: 2434797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia.
    Hock CE; Brezinski ME; Lefer AM
    Eur J Pharmacol; 1986 Mar; 122(2):213-9. PubMed ID: 3011442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
    Smith EF; Carrow BA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    Brezinski ME; Darius H; Lefer AM
    Arzneimittelforschung; 1986 Mar; 36(3):464-6. PubMed ID: 3707665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
    Schrör K; Thiemermann C
    Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE; Lefer DJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.
    Fiddler GI; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusion.
    Hock CE; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):285-94. PubMed ID: 3755540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thromboxane receptor blockade on oxygen supply/consumption variables during reperfusion in the anesthetized dog.
    Grover GJ; Sleph PG; Weiss HR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1097-102. PubMed ID: 2141635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of ischemic myocardium by pinane thromboxane A2.
    Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
    Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective actions of propyl gallate, a lipoxygenase inhibitor, on the ischemic myocardium.
    Leprán I; Lefer AM
    Circ Shock; 1985; 15(2):79-88. PubMed ID: 3919959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
    Tsao PS; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):205-11. PubMed ID: 2148980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
    Osborne JA; Lefer AM
    Am J Physiol; 1988 Aug; 255(2 Pt 2):H318-24. PubMed ID: 2970233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids.
    Lefer AM; Burke SE; Lepran I
    Can J Physiol Pharmacol; 1984 Dec; 62(12):1487-91. PubMed ID: 6241500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor.
    Burke SE; DiCola G; Lefer AM
    J Cardiovasc Pharmacol; 1983; 5(5):842-7. PubMed ID: 6195474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.